Erdolin Capsule

Symptomatic treatment of acute exacerbations of, chronic bronchitis, in adults as an expectorant.

Oral As a mucolytic Adult: 300 mg bid. Max duration: 10 days. Hepatic Failure Since there are no data in patients with severe liver failure, the use of erdosteine is not recommended in these patients. Mild to Moderate Hepatic Failure Dose should be reduced

Since there are no data in patients with creatinine clearance <25ml/min, the use of erdosteine is not recommended in these patients.

The capsules must be swallowed whole with a glass of water.

Hypersensitivity to the active substance or to any of the other excipients. Active peptic ulcer.

Pregnancy, lactation.

Not Classi

Epigastralgia, nausea, vomiting, loose stools, spasmodic colitis, headache.

Erdosteine contains two sulfhydryl groups, which are freed after metabolic transformation in the liver. The liberated sulfhydryl groups break the disulphide bonds, which hold the glycoprotein fibres of mucus together. This makes the bronchial secretions more fluid and enhances elimination.

Erdolin 300 mg Capsule manufactured by UniMed UniHealth Pharmaceuticals Ltd.. Its generic name is Erdosteine.